Oxidative modification of albumin in the parenchymal lung tissue of current smokers with chronic obstructive pulmonary disease

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Hackett, Tillie L ^a,b   Scarci, Marco ^c   Zheng, Lu ^b   Tan, Wan ^b   Treasure, Tom ^c   Warner, Jane A ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HUMAN SERUM ALBUMIN; OXIDIZED HUMAN SERUM ALBUMIN; UNCLASSIFIED DRUG; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LUNG FUNCTION; LUNG PARENCHYMA; LUNG RESECTION; MALE; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; SMOKING; LUNG; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; TISSUE DISTRIBUTION;

AGED; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SERUM ALBUMIN; SMOKING; TISSUE DISTRIBUTION;

EID: 78650357239     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-180     Document Type: Article

References (37)

1. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2(1):50-60. 10.1513/pats.200411-056SF, 16113469.
2. Bowler RP, Barnes PJ, Crapo JD. The role of oxidative stress in chronic obstructive pulmonary disease. Copd 2004, 1(2):255-77. 10.1081/COPD-200027031, 17136992.
3. Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993, 686:12-27. 10.1111/j.1749-6632.1993.tb39148.x, 8512242.
4. Cha MK, Kim IH. Glutathione-linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma. Biochem Biophys Res Commun 1996, 222(2):619-25. 10.1006/bbrc.1996.0793, 8670254.
5. Era S, Kuwata K, Imai H, Nakamura K, Hayashi T, Sogami M. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1995, 1247(1):12-6. 10.1016/0167-4838(94)00166-E, 7873580.
6. Soriani M, Pietraforte D, Minetti M. Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. Arch Biochem Biophys 1994, 312(1):180-8. 10.1006/abbi.1994.1297, 8031126.
7. Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. Faseb J 1999, 13(2):233-44.
8. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186:464-78. full_text, 1978225.
9. Davies KJ, Lin SW, Pacifici RE. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. J Biol Chem 1987, 262(20):9914-20.
10. Wright E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006, 60(3):308-14. 10.1111/j.1368-5031.2006.00825.x, 1448694, 16494646.
11. Matsuura E, Kobayashi K, Tabuchi M, Lopez LR. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 2006, 45(6):466-86. 10.1016/j.plipres.2006.05.001, 16790279.
12. Himmelfarb J, McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 2001, 60(1):358-63. 10.1046/j.1523-1755.2001.00807.x, 11422772.
13. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997, 23(3):361-6. 10.1016/S0891-5849(97)00104-4, 9214571.
14. GOLD Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD guidelines 2006 2006, [cited [cited 2007], GOLD., http://WWW.goldcopd.org
15. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163(5):1256-76.
16. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008, 63(12):1046-51. 10.1136/thx.2008.098483, 18786983.
17. Falaschetti E, Laiho J, Primatesta P, Purdon S. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004, 23(3):456-63. 10.1183/09031936.04.00055204, 15065839.
18. Schleimer RP, Schulman ES, MacGlashan DW, Peters SP, Hayes EC, Adams GK, et al. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest 1983, 71(6):1830-5. 10.1172/JCI110938, 370388, 6134755.
19. Duthie GG, Arthur JR, Beattie JA, Brown KM, Morrice PC, Robertson JD, et al. Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease. Ann N Y Acad Sci 1993, 686:120-9. 10.1111/j.1749-6632.1993.tb39165.x, 8512243.
20. Pelletier O. Vitamin C and cigarette smokers. Ann N Y Acad Sci 1975, 258:156-68.
21. Anderson R, Theron AJ, Ras GJ. Ascorbic acid neutralizes reactive oxidants released by hyperactive phagocytes from cigarette smokers. Lung 1988, 166(3):149-59. 10.1007/BF02714043, 3132577.
22. Tug T, Karatas F, Terzi SM. Antioxidant vitamins (A, C and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease. Clin Invest Med 2004, 27(3):123-8.
23. Murray JC, Demopulos CM, Lawn RM, Motulsky AG. Molecular genetics of human serum albumin: restriction enzyme fragment length polymorphisms and analbuminemia. Proc Natl Acad Sci USA 1983, 80(19):5951-5. 10.1073/pnas.80.19.5951, 390195, 6310605.
24. Koot BG, Houwen R, Pot DJ, Nauta J. Congenital analbuminaemia: biochemical and clinical implications. A case report and literature review. Eur J Pediatr 2004, 163(11):664-70.
25. Reznick AZ, Cross CE, Hu ML, Suzuki YJ, Khwaja S, Safadi A, et al. Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem J 1992, 286(Pt 2):607-11. 1132941, 1530591.
26. O'Neill CA, Halliwell B, van der Vliet A, Davis PA, Packer L, Tritschler H, et al. Aldehyde-induced protein modifications in human plasma: protection by glutathione and dihydrolipoic acid. J Lab Clin Med 1994, 124(3):359-70.
27. Lenz AG, Costabel U, Maier KL. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur Respir J 1996, 9(2):307-12. 10.1183/09031936.96.09020307, 8777969.
28. Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996, 51(4):348-50. 10.1136/thx.51.4.348, 1090665, 8733482.
29. Foreman RC, Mercer PF, Kroegel C, Warner JA. Role of the eosinophil in protein oxidation in asthma: possible effects on proteinase/antiproteinase balance. Int Arch Allergy Immunol 1999, 118(2-4):183-6. 10.1159/000024061, 10224372.
30. Hastings RH, Folkesson HG, Petersen V, Ciriales R, Matthay MA. Cellular uptake of albumin from lungs of anesthetized rabbits. Am J Physiol 1995, 269(4 Pt 1):L453-62.
31. Grune T, Davies KJ. Breakdown of oxidized proteins as a part of secondary antioxidant defenses in mammalian cells. Biofactors 1997, 6(2):165-72. 10.1002/biof.5520060210, 9259998.
32. Das S, Horowitz S, Robbins CG, el-Sabban ME, Sahgal N, Davis JM. Intracellular uptake of recombinant superoxide dismutase after intratracheal administration. Am J Physiol 1998, 274(5 Pt 1):L673-7.
33. Anraku M, Yamasaki K, Maruyama T, Kragh-Hansen U, Otagiri M. Effect of oxidative stress on the structure and function of human serum albumin. Pharm Res 2001, 18(5):632-9. 10.1023/A:1011029226072, 11465418.
34. Swart PJ, Beljaars L, Kuipers ME, Smit C, Nieuwenhuis P, Meijer DK. Homing of negatively charged albumins to the lymphatic system: general implications for drug targeting to peripheral tissues and viral reservoirs. Biochem Pharmacol 1999, 58(9):1425-35. 10.1016/S0006-2952(99)00224-5, 10513986.
35. Duryee MJ, Freeman TL, Willis MS, Hunter CD, Hamilton BC, Suzuki H, et al. Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol Pharmacol 2005, 68(5):1423-30. 10.1124/mol.105.016121, 16105988.
36. Lang JD, McArdle PJ, O'Reilly PJ, Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest 2002, 122(6 Suppl):314S-20S. 10.1378/chest.122.6_suppl.314S, 12475808.
37. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JM, Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004, 32(3):755-9. 10.1097/01.CCM.0000114574.18641.5D, 15090958.